Table 2.

Number of CFU-MK, BFU-E, CFU-E, GM-CFC, CFU-mix, and CFU-GEMM Colonies Derived From BM Cells of Control Nontransgenic, HαIIb-tk, and MαIIb-tk Mice Treated With GCV

CFU-MKBFU-ECFU-EGM-CFCCFU-mixCFU-
GEMMK
Control 6 ± 2 10 ± 3 52 ± 12 62 ± 9 10 ± 3 7 ± 2 
HαIIb-tk 1 ± 1 0 ± 1 46 ± 8 60 ± 6 0 ± 1 
MαIIb-tk 1 ± 1 1 ± 1 37 ± 12 59 ± 4 0 ± 1 0 ± 1 
CFU-MKBFU-ECFU-EGM-CFCCFU-mixCFU-
GEMMK
Control 6 ± 2 10 ± 3 52 ± 12 62 ± 9 10 ± 3 7 ± 2 
HαIIb-tk 1 ± 1 0 ± 1 46 ± 8 60 ± 6 0 ± 1 
MαIIb-tk 1 ± 1 1 ± 1 37 ± 12 59 ± 4 0 ± 1 0 ± 1 

Marrow cells from control, HαIIb-tk (one copy of the transgene integrated) and MαIIb-tk (several copies integrated) mice treated with 0.1 mg of GCV/day/g body weight were obtained by femoral aspiration cultured as described in Materials and Methods. Each number (±SD) is the mean of three wells in three different experiments. CFU-mix colonies consisted of erythroid and megakaryocytic component, granulocytic, macrophagic, and erythroid component, or granulocytic macrophagic megakaryocytic without an erythroid component and multipotent CFU-GEMMK (granulocytic, erythrocytic macrophagic and megakaryocytic components).

or Create an Account

Close Modal
Close Modal